Hostname: page-component-669899f699-7xsfk Total loading time: 0 Render date: 2025-04-26T04:43:30.306Z Has data issue: false hasContentIssue false
  • English
  • Français

Case report: 3D-printed model for surface mould preparation on a patient with Down’s syndrome

Published online by Cambridge University Press:  22 May 2023

Iqbal Al Amri Open the ORCID record for Iqbal Al Amri [Opens in a new window] ,
Rohit Inippully Somasundaran ,
Mahmoud Al Fishawy ,
Nirmal Babu ,
Hajir Sulaiman Al Siyabi  and
Mohammad Al Ghafri
Iqbal Al Amri*
Affiliation:
Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman
Rohit Inippully Somasundaran
Affiliation:
Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman
Mahmoud Al Fishawy
Affiliation:
Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman
Nirmal Babu
Affiliation:
Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman
Hajir Sulaiman Al Siyabi
Affiliation:
Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman
Mohammad Al Ghafri
Affiliation:
Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman
*
Corresponding author: Iqbal Al Amri, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman. E-mail: i.alamri@cccrc.govom
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

A patient with Down’s syndrome, with dermatofibrosarcoma protuberans, was intended for adjuvant radiotherapy. The lesion was on the parietal region of the head of the patient. Given the proximity of the lesion to the brain, the curvature of the lesion, and potential complications of anaesthesia for a Down’s syndrome patient, brachytherapy was the appropriate treatment. Anaesthesia complications for patients with Down’s syndrome are airway infections, atlanto-occipital dislocation and bradycardia.

Method:

Instead of sedating the patient in order to prepare a mould applicator, a 3D-printed model of the patient’s head was used. This allowed us greater time to prepare the applicator in a more relaxed environment.

Result:

The fit of the mould applicator on the patient was satisfactory. Minimum air gaps were observed. The treatment could be completed with sedation only.

Conclusion:

We were able to achieve an equivalent dose of 44·69 Gy in 5 sessions of brachytherapy, significantly reducing the anaesthesia sessions and the associated risks. A drawback of 3D printing is that it takes several hours to print the model.

Keywords

3D printingbrachytherapydermatofibrosarcoma protuberansDown’s syndromegeneral anaesthesiasurface mould
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 22 , 2023 , e98
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Williams, N, Morris, CG, Kirwan, JM, Dagan, R, Mendenhall, WM Radiotherapy for dermatofibrosarcoma protuberans. Am J Clin Oncol 2014; 37 (5): 430–432. doi: 10.1097/COC.0b013e31827dee86. PMID: 23388563.CrossRefGoogle ScholarPubMed
Kobel, M, Creighton, RE, Steward, DJ Anaesthetic considerations in Down’s’s syndrome: experience with 100 patients and a review of the literature. Canad Anaesth Soc J 1982; 29: 593–599. https://doi.org/10.1007/BF03007747 CrossRefGoogle Scholar
Borland, LM, Colligan, J, Brandom, BW Frequency of anesthesia-related complications in children with Down’s syndrome under general anesthesia for noncardiac procedures. Pediatric Anesthesia 2004; 14: 733–738. https://doi.org/10.1111/j.1460-9592.2004.01329.x CrossRefGoogle ScholarPubMed
Jamora, KE, Cereno, REP, Inocencio, ET, Hizon, VFR Demratofibrosarcoma protuberans of the upper eyelid treated with surface mould high-dose-rate brachytherapy. Rep Pract Oncol Radiother 2022. DOI: 10.5603/RPOR.a2021.0110 CrossRefGoogle ScholarPubMed
Bandyopadhyay, A, Basu, P, Biswas, S, Ghosh, S Dermatofibrosarcoma protruberans of the scalp treated with customised surface mould high-dose-rate (HDR) brachytherapy: a case report. J Radiother Pract 2018; 17 (4): 455–459. doi: 10.1017/S1460396918000110 CrossRefGoogle Scholar
Pugh, R, Lloyd, K, Collins, M, Duxbury, A The use of 3D printing within radiation therapy to improve bolus conformity: a literature review. J Radiother Pract 2017; 16 (3): 319–325. doi: 10.1017/S1460396917000115 CrossRefGoogle Scholar
Craft, DF, Howell, RM Preparation and fabrication of a full-scale, sagittal-sliced, 3D-printed, patient-specific radiotherapy phantom. J Appl Clin Med Phys 2017; 18: 285–292. https://doi.org/10.1002/acm2.12162 CrossRefGoogle ScholarPubMed
Avelino, SR, Silva, LFO, Miosso, CJ “Use of 3D-printers to create Intensity-Modulated Radiotherapy Compensator Blocks,” 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2012, pp. 5718–5721, doi: 10.1109/EMBC.2012.6347293.CrossRefGoogle Scholar
Zou, W, Fisher, T, Zhang, M et al. Potential of 3D printing technologies for fabrication of electron bolus and proton compensators. J Appl Clin Med Phys 2015; 16: 90–98. https://doi.org/10.1120/jacmp.v16i3.4959 CrossRefGoogle ScholarPubMed
Arenas, M, Sabater, S, Sintas, A et al. Individualized 3D scanning and printing for non-melanoma skin cancer brachytherapy: a financial study for its integration into clinical workflow. J Contemp Brachytherapy 2017; 9 (3): 270–276. https://doi.org/10.5114/jcb.2017.68134 CrossRefGoogle ScholarPubMed
Casey, S, Awotwi-Pratt, J, Bahl, G Surface mould brachytherapy for skin cancers: The British Columbia cancer experience. Cureus 2019; 11 (12): e6412. doi: 10.7759/cureus.6412. PMID: 31988814; PMCID: PMC6970095.Google ScholarPubMed
Nath, R, Anderson, LL, Luxton, G, Weaver, KA, Williamson, JF, Meigooni, AS Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys. 1995; 22 (2): 209–234. doi: 10.1118/1.597458. Erratum in: Med Phys 1996 Sep;23(9):1579. PMID: 7565352.CrossRefGoogle ScholarPubMed
Bassi, S, Langan, B, Malone, C Dosimetry assessment of patient-specific 3D printable materials for HDR surface brachytherapy. Phys Med 2019; 67: 166–175, ISSN 1120-1797, https://doi.org/10.1016/j.ejmp.2019.10.035.CrossRefGoogle ScholarPubMed
Fowler, FL, Buyyounouski, MK, Jenkins, CH, Fahimian, BP Clinical implementation of 3D printing for brachytherapy: techniques and emerging applications. Brachytherapy 15, 166, https://doi.org/10.1016/j.brachy.2016.04.297 CrossRefGoogle Scholar
Fedorov, A, Beichel, R, Kalpathy-Cramer, J et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 2012; 30 (9): 1323–1341. PMID: 22770690. PMCID: PMC3466397.CrossRefGoogle ScholarPubMed
Boman, EL, Satherley, TWS, Schleich, N, Paterson, DB, Greig, L, Louwe, RJW. The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments. Brachytherapy 2017; 16 (6): 1280–1288. doi: 10.1016/j.brachy.2017.08.010. Epub 2017 Sep 28. PMID: 28967561.CrossRefGoogle ScholarPubMed
Granero, D, Perez-Calatayud, J, Vijande, J, Ballester, F, Rivard, MJ Limitations of the TG-43 formalism for skin high-dose-rate brachytherapy dose calculations. Med Phys 2014; 41: 021703. https://doi.org/10.1118/1.4860175 CrossRefGoogle ScholarPubMed